Pharmacy |
| ||
|
Casodex Generic Bicalutamide |
|
| ||
Home » Prescription Drugs 3 » Casodex Generic Bicalutamide Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Bicalutamide is an antiandrogen. It works in the body by preventing the actions of androgens (male hormones). Bicalutamide is used in the treatment of prostate cancer. Nonsteroidal antiandrogens are used to treat cancer of the prostate gland. The prostate gland is present only in males; therefore females do not get prostate cancer. CASODEX 50 mg daily is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analogue for the treatment of Stage D2 metastatic carcinoma of the prostate. Buy Casodex Generic Bicalutamide and other Prescription Drugs 3 products online at Medstore. 3645
About Casodex Generic Bicalutamide: Product Type: Prescription Drugs 3 Casodex ( Generic Bicalutamide ) Casodex (Generic Bicalutamide) Generic Bicalutamide 50mg 28 Tablets Generic Bicalutamide Casodex
View more Prescription Drugs 3 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
